25 Feb 2026 16:42 CET

Issuer

Nordhealth AS

Nordhealth will report and present its Q4 2025 results on Tuesday the 3rd of
March 2026.

The results will be presented in a live presentation and subsequent Q&A session
with CEO Charles MacBain and CFO Alexander Cram on the 3rd of March at 13:00
CET.

Please use the following link to attend: https://us02web.zoom.us/j/86230116204

The presentation will be recorded and made available on www.nordhealth.com. The
presentation material for Q4/2025 will be available on 3rd March 2026 at 07:30
CET
on www.newsweb.no (https://publish.ne.cision.com/l/uxskchlrc/publish.ne.cision.c
o
m/l/afkpudtpe/www.newsweb.no) and on Nordhealth's IR
website https://nordhealth.com/investor/news-and-documents/

For further information, please contact:

Charles MacBain, CEO charles.macbain@nordhealth.com

Alexander Cram, CFO alexander.cram@nordhealth.com

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS
company on a mission to redefine digital healthcare. We build software that
empower veterinary and therapy professionals to provide the best possible care
experiences to their patients. Our products serve more than 60,000 veterinary
and therapy professionals across 13,000 clinics and hospitals located in over 30
countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the
Nordic region and a growing presence internationally, with 400 employees working
either remotely or from offices (collaboration hubs). Visit the company's
website at nordhealth.com (http://www.nordhealth.com).


Source

Nordhealth AS

Provider

Oslo Børs Newspoint

Company Name

NORDHEALTH AS A-AKSJER

ISIN

NO0011002651

Symbol

NORDH

Market

Euronext Growth